Dr Magdalena Radwanska

Professor Dr. Magdalena Radwanska obtained her PhD from the Université Libre de Bruxelles, Belgium. She has extensive scientific expertise in molecular diagnostics, biomarker discovery, and vaccine development against various infectious diseases. She is a post-doctoral fellow of the Tufts University, MA, USA and the University of Cape Town, South Africa. She served as a senior R&D manager at the Foundation for Innovative New Diagnostics (FIND) in Geneva, Switzerland, under a patronage of the Bill & Melinda Gates Foundation. She managed biomedical research projects on a pan-European scale and provided advice on research priorities for Science Europe, Brussels, Belgium. Professor Radwanska joined the GUGC in 2015. She teaches Microbiology, Molecular Biological Analysis, Animal Biology, and Immunology. Research Area Research conducted at the Biomedical Research Center focuses on understanding of various mechanisms underlying B cell dysfunction and vaccine failure against parasitic (T. brucei) and bacterial diseases (B. pertussis). In particular, Professor Radwanska is interested in the events triggering apoptosis in B cells leading to the loss of memory responses. Various gene candidates are being analyzed with the purpose of identifying rescue gene targets capable of preventing B cells depletion. In the context of vaccine design, her research includes identification of novel pattern associated molecular patters (PAMPs) and their interactions with corresponding pattern recognition receptors (PRRs). Moreover, conducted vaccination studies also involve the analysis of immunomodulatory properties of molecules derived from microorganisms present in fermented food such as kimchi and the role of microbiome. Currently various research projects are performed in collaboration with the Vrije Universiteit Brussel and Ugent University, Belgium, as well as Korea University